Fifty-four college women with symptoms of lower urinary tract infections were randomly treated, 25 with 500 mg of ceftriaxone in a single intramuscular dose and 29 with 160 mg of trimethoprim-800 mg of sulfamethoxazole orally twice daily for 7 days. At 1 week after treatment, 23 patients (92%) in the ceftriaxone group and 28 patients (96%) in the trimethoprim-sulfamethoxazole group were cured. Responses of the patients with positive or negative antibody-coated bacteria tests were not significantly different. Four patients (16%) in the ceftriaxone group developed diarrhea and malaise. One patient (4%) in the trimethoprim-sulfamethoxazole group had medication discontinued because of headaches. Leukopenia was found in one patient (4%) in the ceftriaxone group and four patients (14%) in the trimethoprim-sulfamethoxazole group.Single-dose regimens of a variety of antimicrobial agents have been found effective in the treatment of acute uncomplicated urinary tract infections (UTIs) (2, 13, 24; A. Iravani and G. A. Richard, Pediatr. Res. 15:443, 1981). Cephalosporins are effective against most common urinary tract pathogens (16), but their administration as a single dose for UTIs is controversial (5,15,23,27). Ceftriaxone is a new, parenterally administered cephalosporin with an expanded antibacterial activity (6,10,21). Its plasma elimination half-life is about 8 h (four times longer than that of other cephalosporins), and it is excreted in its active form in high concentrations in the urine (7,25,26,28).The purposes of this trial were (i) to compare the efficacy and safety of a single intramuscular dose of ceftriaxone with multiple oral doses of trimethoprim-sulfamethoxazole for treatment of UTIs in college women, (ii) to relate therapeutic responses to the results of antibody-coated bacteria test (ACBT), and (iii) to assess the emergence of resistant Enterobacteriaceae in the urogenital and rectal areas.
MATERIALS AND METHODSPatient criteria. Fifty-four college women with symptoms of acute cystitis were enrolled in the study at the Kidney Clinic of the University of Florida Student Health Service. The major criteria for inclusion in this study were (i) the presence of at least one bacterium in each random highpower microscopic field of uncentrifuged and unstained samples of two urine specimens and (ii) 2105 CFU of the same bacterium per ml in each of the two urine specimens. Excluded were pregnant or lactating women, patients who had received antimicrobial therapy during the preceding week, and those with fever (238°C), flank pain, impaired renal or liver function, radiographically proven obstructive uropathy, history of glucose 6-phosphate dehydrogenase deficiency, or allergy to cephalosporins, trimethoprim, or sulfonamides.Collection and processing of specimens. Two clean-catch, midstream urine specimens were obtained from each patient within 24 h before treatment began. Before and 1 week after the end of treatment, specimens were collected from vagi-* Corresponding author. nal, periurethral, and rectal areas by C...